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Abstract
Background: The majority of gastric cancer cases are believed to be caused by chronic infection with the
bacterium Helicobacter pylori, and atrophic corpus gastritis is a predisposing condition to gastric cancer development.
We aimed to increase understanding of the molecular details of atrophy by performing a global transcriptome analysis
of stomach tissue.
Methods: Biopsies from patients with different stages of H. pylori infection were taken from both the antrum
and corpus mucosa and analyzed on microarrays. The stages included patients without current H. pylori infection,
H. pylori-infected without corpus atrophy and patients with current or past H. pylori-infection with corpus-predominant
atrophic gastritis.
Results: Using clustering and integrated analysis, we found firm evidence for antralization of the corpus mucosa of
atrophy patients. This antralization harbored gain of gastrin expression, as well as loss of expression of corpus-related
genes, such as genes associated with acid production, energy metabolism and blood clotting. The analyses provided
detailed molecular evidence for simultaneous intestinal metaplasia (IM) and spasmolytic polypeptide expressing
metaplasia (SPEM) in atrophic corpus tissue. Finally, acidic mammalian chitinase, a chitin-degrading enzyme produced
by chief cells, was shown to be strongly down-regulated in corpus atrophy.
Conclusions: Transcriptome analysis revealed several gene groups which are related to development of corpus
atrophy, some of which were increased also in H. pylori-infected non-atrophic patients. Furthermore, loss of acidic
chitinase expression is a promising marker for corpus atrophy.
Keywords: Corpus gastritis, Gastric cancer, Integrated analysis, Acidic mammalian chitinase
Background
Chronic infection with the bacterium Helicobacter pylori
(Hp) can have dire consequences. The majority of
infected individuals remain symptom-free, but 10-15%
develop peptic ulcers, and 1-3% develop gastric cancer
(GC) [1]. Hp-infected subjects are estimated to have up to
12 times increased risk of developing GC, and eradication
of H. pylori reduces the risk of developing disease [2].
Gastric cancer is today the second largest cause of can-
cer mortality worldwide with more than 700 000 deaths
annually [3].
A hallmark in the progression towards the intestinal
type of GC is the presence of atrophic gastritis. It is well
established that atrophy of the corpus mucosa, with
accompanying loss of parietal cells and thereby decreased
acid secretion, is highly associated to GC development.
Alongside with corpus atrophy, there is often antralization
of the corpus mucosa. This is also termed pseudopyloric
metaplasia [4] meaning that the atrophic corpus mucosa
attains the general appearance of antral mucosa. Recently,* Correspondence: samuel.lundin@gu.se†Equal contributors
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a new lineage of metaplastic cells has gained increased
attention - the spasmolytic polypeptide expressing
metaplasia (SPEM) cells. These cells develop in the
atrophic pits and appear to arise from either a cryptic
progenitor cell population in the base of the fundic
glands, or from trans-differentiated chief cells [5]. SPEM,
which is characterized by strong expression of trefoil
factor 2 (TFF2), has been suggested to be present in all
atrophy of the corpus [6]. The molecular details of
atrophy development, antralization and SPEM, however,
are poorly understood and there is a lack of knowledge
of the disease progression. Therefore, understanding of
the progression towards GC in better detail constitutes
an important research area. In the present study, we set
out to analyze the genome-wide gene expression of
both corpus and antrum mucosa in patients with current
or past H. pylori-infection and suffering from atrophic
gastritis (Atr group), as well as in H. pylori-infected
patients with non-atrophic gastritis, and patients without
current H. pylori-infection. The analysis was done using
oligonucleotide microarray, followed by detailed systems
analysis. This experimental set up, which was based on
the disease progression, allowed for the elucidation of
the molecular patterns and processes associated with
H. pylori-induced atrophy in the corpus mucosa.
Methods
Patient recruitment and sample collection
The study was approved by the Human Research Ethics
Committee at University of Gothenburg and informed oral
and written consent was obtained from each volunteer
before participation. Patients were selected from a con-
secutive cohort of patients undergoing gastroendoscopy
at Sahlgrenska University Hospital, Gothenburg, during
2007–2009. These patients had been admitted to endos-
copy due to dyspepsia, malabsorption or anemia. Patients
not suffering from extragastric malignancy or inflammatory
disease were carefully grouped into three groups, based on
histopathological scoring according to the Sydney system,
in combination with H. pylori culture and serology results;
1. no current H. pylori infection (Hp-); 2. current H. pylori
infection without corpus-predominant atrophic gastritis
(Hp+); 3. current or past H. pylori infection and corpus-
predominant atrophic gastritis (Atr) (see details in Table 1).
For details of sampling procedures and H. pylori serology,
see Additional file 1.
Table 1 Information about of all patients included in the study
Age Gender Group Analyses performed1 Neutrophils2 Mononuclear cells2 Atrophy2 Intestinal metaplasia2
Array qPCR WB Antrum Corpus Antrum Corpus Antrum Corpus Antrum Corpus
70 Male Atr Yes Yes 0 1 2 2 1 2 0 0
41 Male Hp+ Yes 2 1 1 1 1 1 0 1
79 Female Hp+ Yes 2 1 3 2 2 1 1 0
61 Male Atr Yes 0 1 0 2 0 2 0 0
62 Male Atr Yes Yes 0 0 1 1 1 3 2 3
78 Male Hp- Yes 1 0 1 1 1 1 2 1
68 Male Hp+ Yes Yes 0 1 1 1 0 0 0 0
33 Male Hp+ Yes 0 0 2 1 0 0 0 0
65 Female Hp+ Yes Yes 1 1 2 2 0 0 0 0
60 Female Hp+ Yes Yes 0 0 1 1 0 0 0 0
63 Male Hp- Yes 0 0 2 0 0 0 0 0
63 Female Atr Yes 0 1 1 2 0 2 0 0
81 Female Atr Yes 0 0 1 2 0 2 0 1
46 Male Atr Yes 1 1 2 2 0 2 1 1
71 Male Hp- Yes Yes 0 0 1 0 0 0 0 0
82 Male Hp- Yes Yes 0 0 0 0 0 0 0 0
55 Male Hp- Yes 0 0 0 0 0 0 0 0
42 Female Atr Yes Yes 1 3 2 3 0 2 0 0
67 Female Hp- Yes Yes 0 0 0 0 1 0 0 0
74 Male Hp+ Yes 2 1 2 2 1 1 1 1
56 Female Hp+ Yes 0 0 2 0 0 0 0 0
1The assays performed, using samples from each individual patient, are shown.
2Paraffin-embedded sections were analyzed and scored according to the Updated Sydney system (Am J Surg Path 1996:20:1161), where scores may be judged 0
(absent), 1 (mild), 2 (moderate) and 3 (severe).
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Microarray experiment
For the microarray experiments, three patients were
randomly selected for analysis from the Hp- and Hp +
groups. From the Atr group, the three patients with
most progressed lesions according to the histopathology
analysis were selected. These three patients had moderate
or marked atrophy (score 2 or 3) and mild, moderate or
marked intestinal metaplasia (score 1 to 3) in their corpus
tissue. The Illumina’s BeadArray technology was used
for transcriptome analysis. cRNA amplification and biotin
labeling from 500 ng of total RNA were performed using
Illumina® TotalPrep RNA amplification kit (Ambion, Inc.,
Austin, TX). cRNA yields were quantified with NanoDrop®
(Thermo Scientific, Wilmington, DE). Labeled cRNAs
(1.5 μg) were hybridized to the Human-8 v2 Expression
Beadchips (Illumina, Inc., San Diego, CA) then incubating
for 19 h at 58°C before being washed and stained following
the manufacturer’s protocol. Beadchips were then scanned
using the IlluminaBeadArray-Reader scanner. Signal ex-
traction and primary quality control was carried out with
BeadStudio 3.1.7 software (Illumina Inc., San Diego, CA).
Microarray data acquisition and analysis
All raw signal intensity files from the BeadStudio were
processed together by R software equipped ‘lumi’ package
[7] using quantile normalization. We used different
methods to analysis the microarray data based on different
hypotheses. First, the differential gene expressions
between the corpus and antrum samples of each group
of patients were evaluated by Student’s t test (‘limma’
package) [8]. The results are illustrated in global view
in Figure 1A and the numbers of differential expressed
genes (cutoff p-value < 0.05) of each group are illustrated
in Figure 1B. Thereafter, the gene ontology (GO) enrich-
ment of the antrum and corpus samples in each group of
patients was revealed by a reporter algorithm [9,10]. The
GOs that had enrichment p-value < 0.001 were illustrated
in Figure 2 as a heat-map of significant values. Second, the
gene expression was analyzed by one-way ANOVA to
identify differences among the three patient groups. This
was done separately for antrum and corpus samples. The
gene expressions that had p-value < 0.001 were further se-
lected for consensus-clustering analysis [11]. Hierarchical
clustering of gene expression profiles were performed
separately for corpus and antrum samples. The results
are presented as a heat-map of gene expression similarity,
using a cluster dendrogram height of 1.3. Functional
enrichments of each cluster were then evaluated by
module enrichment analysis [12] of its gene members,
and illustrated using Cytoscape software [13] as illus-
trated in Figure 3. Third, linear regression analysis was
performed over the selected genes based on ANOVA, as
A B
Figure 1 Differences in global gene expression between antrum and corpus samples in different patient groups. A. The negative
logarithms of p-values for the difference in expression between antrum and corpus tissues are shown as the length of each spike in the circle
diagrams (i.e. 8 equals p = 10-8), Hp- (green), Hp + (yellow) and Atr (red). All genes in the microarray are shown; the chromosomal location of
each gene is indicated by the circle sections in clock-wise direction (chromosome I to XXII). B. The number of differentially expressed genes in
antrum compared to corpus tissue in Hp-, Hp + and Atr groups, respectively. The sections, and their corresponding numbers, indicate the number
of genes significantly different between antrum and corpus in only one patient group (colored sections), or genes for which a difference
between antrum and corpus was found in two or three patient groups (patterned sections). The cut-off for inclusion in the figure was a p-value
< 0.05 for the comparison between antrum and corpus in each patient group.
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described above, to estimate the level of gene expression
responses along the three groups of patients. An overview
of the analysis layout, and detailed results are provided in
Supplementary information (Additional file 1: Figure S1
and Additional file 2).
The microarray results were not subjected to FDR-
analysis or multiple-test correction. This is due to the fact
that we were limited in the number of well-characterized
tissue samples we could obtain from each patient group.
However, the key findings in this study were validated
with real-time PCR as well as the protein abundance
level. The microarray data are deposited and publicly
available in Gene Expression Omnibus (GEO; Accession
number GSE27411).
Tissue and cell type specific evaluation of gene clusters
To investigate whether the list of genes up-regulated in
atrophic gastritis were enriched in genes with tissue-
specific expression patterns, we used a publicly available
reference dataset “Human Body Index – Transcriptional
Figure 2 GO analysis of gene expression differences between antrum and corpus samples in different patient groups. The ontologies
were grouped based on pattern of difference in Hp-, and then further subdivided manually for functional similarity (g1-g7). The “All” column
indicates two-tailed analysis, while the results for up-regulation in antrum tissue are shown in the “Antrum” column, and up-regulation in corpus
tissue is shown in the “Corpus” column. Arrows indicate the fraction of expression direction of gene member in each ontology (Up arrows = all
genes were up-regulated in Corpus, Down arrows = all genes were up-regulated in Antrum). The arrow was drawn when p-value < 0.01. The
color-coding indicates the p-values for enrichment of each ontology; i.e. green equals p-values = 10-1, and red equals p-values = 10-8.
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Figure 3 (See legend on next page.)
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Profiling” (GEO-accession number GSE7307). All data
were normalized together with the qspline algorithm
[14] with signal processing method by Probe Logarithmic
Intensity Error [15]. Genes were assayed for tissue specifi-
city compared to small intestine, colon, antrum (“pyloric”),
and cardiac/fundus tissue after verifying the validity of
the data through hierarchical clustering of the tissues.
Genes were analyzed using Wilcoxon rank-sum test and
considered tissue specific if they had a p-value < 10-3 and
a fold change of > 2. The tissue specific genes were then
tested for enrichment in the different clusters of Figure 3
using Fisher exact test. The genes in different clusters also
tested against the list of genes differentially expressed in
IM, SPEM and both IM and SPEM from the recent
publication by Lee et al. 2010 [16].
RT-qPCR assay of selected genes
Selected genes from the microarray analysis were inde-
pendently validated by RT-qPCR analysis. cDNA synthe-
sis from 600 ng of RNA were performed by Omniscript
RT kit (Qiagen, Germany). Each 20 μl RT-qPCR reaction
mixture included 2 μl of the cDNA product, 17 μl SYBR
Green master mixture (Applied Biosystems) and primers
(Additional file 1: Table S1). All assays were performed
in technical duplicates using a 7500 Real Time PCR
System (Applied Biosystems). Hypoxanthine-phophori-
bosyl-transferase (HPRT1), which has previously been
observed to be a good reference gene for normal stomach
tissue [17], was used as a reference gene for all assays
to normalize expression by the ΔCt method [18].
Western blot assay of acidic mammalian chitinase protein
in stomach
One or two biopsies from antrum and corpus mucosa,
respectively, were collected and stored for protein extrac-
tion as described above.
At the time of protein extraction, biopsy specimens
were incubated in 400 μl PBS, containing 2% saponin,
100 mg/ml soybean trypsin inhibitor, 350 mg/ml phenyl-
methylsulfonylfluoride and 0.1% bovine serum albumin
(all purchased from Sigma-Aldrich, St.Louis, MO, USA),
over night at 4°C. The mixtures were then centrifuged at
13000 × g for 10 minutes, and the supernatants were
collected and stored frozen at −70°C until used. To ensure
equal loading of total protein in the gels, the extracts were
run through Zeba Micro Desalt Spin Columns (Nordic
Biolab labdesign, Täby, Sweden), whereafter their protein
concentrations were determined using BCA Protein Assay
reagent (Thermo Fisher Scientific, Rockford, USA). Three
μg protein of each lysate was loaded per lane in 4-12%
BisTris NuPAGE gels (Invitrogen, Carlsbad, CA) and gels
were run in MOPS (3-[N-morpholino]propane sulfonic
acid) buffer at 200 V. Proteins were transferred to 0.22 μm
nitrocellulose membranes at 30 V using 25 mM Tris–HCl,
192 mM Glycine and 10% methanol for 1 h. Membranes
were blocked for 1 h in 2% BSA-PBS/Tween. Rabbit
anti-AMCase (ab72309, Abcam, Cambridge, UK) was
used as primary antibody, with chrompure Rabbit IgG
(Jackson Immuno, Suffolk, UK) as unspecific control.
After washes in PBS + 0.1% Tween-20, Goat anti-Rabbit
Immunoglobulins-alkaline phosphatase (Southern Biotech,
Birmingham, AL) was added and after subsequent washes
the blots were developed using 5-bromo-4-chloro-3-in-
dole-phosphate/nitro blue tetrazolium (Southern Biotech,
Birmingham, AL). The membranes were scanned with a
Geldoc (Bio-Rad Laboratories, Hercules, CA) scanner, and
band intensities were analyzed using Quantity One 4.6.1
software (Bio Rad).
Results
Confirmation of differences between antrum and
corpus samples
We first performed an initial quality check of the micro-
array data, by investigating the expression of a number
or cell-specific genes known to be preferentially expressed
either in corpus or antrum tissue. The genes included
the corpus specific genes histidine decarboxylase (HDC),
gastrin receptor (CCKBR), H+/K+ ATPase (ATP4B), ghrelin
(GHRL) and pepsinogen (PGA5), and the antrum-specific
gene gastrin (GAST). The analysis was done using the
data from H. pylori uninfected (Hp-) individuals. We
confirmed a very strong over-expression (10–50 fold)
of the corpus-specific marker genes in corpus biopsies
using the microarray data, and a more than 800-fold
over-expression of the antrum-specific gene gastrin in
antrum samples (Table 2).
Depletion of differential gene expression between
antrum and corpus mucosa in atrophic gastritis
In order to understand the characteristics of the atrophic
corpus mucosa, we applied a global analysis of differential
gene expression between antrum and corpus samples of
the three patient groups. This analysis demonstrated that
the most strongly significant differences between antrum
(See figure on previous page.)
Figure 3 Hierarchical clustering analysis of corpus and antrum gene expression along the patient groups. Genes with differential expression
across the patient groups (p < 0.001, one-way ANOVA) were clustered. The relative expressions of all clustered genes are shown in heat-map form,
where white color indicates down-regulated expression, and red color indicates up-regulated expression. The significantly enriched ontologies are
shown in association to each cluster (bubbles). Related ontologies are depicted by the same color, and are connected by lines. The names of the most
highly significant ontologies are shown in a large font size. For enlargement of all ontology names, see Additional file 1: Figure S3.
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and corpus gene expression are found in the Hp- group,
followed by the Hp + gastritis and atrophy groups
(Figure 1A). There was also a dramatic reduction in the
number of differentially expressed genes in antrum vs.
corpus samples from corpus atrophy patients: 90% and
75% reduction compared to Hp- and Hp + groups,
respectively (Figure 1B). Among these genes, around
equal numbers were over-expressed in antrum and in
corpus. Over-expressed genes in corpus amounted to
54%, 60% and 41% of the differentially expressed genes
in the Hp-, Hp + and Atr groups, respectively. Thus, our
data thus demonstrates molecular evidence for a strong
similarity of global gene expression between corpus and
antrum tissue of patients suffering from corpus atrophy.
This is also supported by the result of a transcriptome
based hierarchical clustering of samples, as shown in
Additional file 1: Figure S2.
Corpus-specific genes in the un-infected stomach include
genes related to acid secretion, energy metabolism, and
blood vessel activity
We then performed an integrated analysis to assess over-
representation of different biological processes among
the genes differentially expressed in antrum compared
to corpus mucosa. This analysis demonstrated that the
absolute majority of gene ontologies coupled to differential
expression between antrum and corpus mucosa in Hp-
individuals were associated with genes over-expressed
in the corpus tissue (Figure 2). Thus, in all 45 ontologies
there was significant enrichment of corpus over-expressed
genes, and in 7 ontologies there was also enrichment of
over-expression of genes in the antrum tissue.
Groups g1 through g4 (Figure 2) encompass ontologies
over-expressed in corpus mucosa in the Hp- group.
Therefore, these groups yield important information
about the functions of genes specific for the corpus
mucosa of Hp- non-atrophic stomach. G1 includes gene-
groups related to gastric acid secretion and H+/K+-ATPase
activity. A large part of the corpus-specific gene ontologies
concern energy turnover and mitochondrial function
(g2) as well as amino acid and lipid metabolism (g3).
The g4 group indicates that an important function of
the corpus mucosa is related to blood vessels and blood
clotting. In this group, genes related to fibrinogen complex,
platelet activation and blood vessel growth were found (see
Additional file 1: Table S2 for details). This is illustrated
most clearly by FGA and FGB, which encode the alpha
and beta chains of fibrinogen, respectively. These genes
were both among the 15 most highly over-expressed in
the corpus compared to antrum of Hp- patients (20- and
31-fold over-expression, respectively). High FGA-expres-
sion in the corpus mucosa is confirmed by the Human
Protein Atlas [19], where very strong patchy staining of
FGA is observed in subepithelial cells of the foveolar
region, while FGB is stained strongly by both epithelial
and subepithelial cells (Additional file 1: Figure S3). The
majority of gene ontologies associated to over-expression
in corpus atrophy mucosa are related to immune response
and inflammation (Figure 2; g6). There were, however, no
differences in either active or chronic inflammation scores
between the Hp + and Atr groups (Table 1), which indicate
that the inflammatory association detected by the global
analysis is related to more subtle inflammatory changes in
the corpus atrophy mucosa.
The similarities of gene expression between antrum and
corpus mucosa in atrophic gastritis is caused by
transcriptional loss of corpus-specific gene groups
In agreement with data shown in Figure 1, the gene
ontology (GO) analysis revealed a relative down-regulation
of a large number of genes in the atrophic corpus mucosa
with the loss of nearly all corpus-specific gene ontologies
in the corpus atrophy group (Figure 2, g1 through g4).
Strikingly, corpus-specific gene groups related to the
acid secretion and the presence of parietal cells showed
no difference between antrum and corpus samples of
atrophy patients.
To enable a more detailed comparison between the
different patient groups, an analysis of gene expression
was performed using hierarchical clustering. While the
Table 2 Gene expression in antrum and corpus tissue of Hp- individuals, for known antrum- and corpus-specific genes
Tissue specificity Cell type Description Symbol ID Fold difference1 p-value2
Corpus ECL-cell Histidine decarboxylase HDC ILMN_98661 11 1.0 x10-4
ECL/Parietal cell Gastrin receptor 1 CCKBR ILMN_9090 15 5.5 x 10-4
Parietal Cell ATPase H+/K+ exchanging, beta ATP4B ILMN_12353 49 1.6 x 10-3
Parietal Cell ATPase H+/K+ exchanging, alpha ATP4A ILMN_16471 45 4.5 x 10-5
Parietal cell Gastric intrinsic factor GIF ILMN_18902 17 1.3 x 10-2
A-like/Gr cell Ghrelin GHRL ILMN_19385 10 5.0 x 10-2
Chief cell Pepsinogen PGA5 ILMN_23664 48 2.4 x 10-2
Antrum G-cell Gastrin GAST ILMN_23553 848 2.8 x 10-5
1 Fold difference when comparing gene expression levels in corpus vs. antrum for corpus specific genes, and antrum vs. corpus for antrum-specific genes.
2 Antrum and corpus expression was compared using Student’s t-test; only values ≤ 0.05 are shown.
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previous analysis (Figures 1 and 2) compared differences
between antrum and corpus samples within individual
patients, the hierarchical clustering approach compared the
gene expression of antrum and corpus samples separately,
across the different patient groups. While only 356 genes
were captured by the ANOVA cut-off (p-values < 0.001) in
antrum samples, there were 1395 differentially expressed
genes in the corpus samples. A clustering dendrogram
clearly further divided the expression pattern into 4 and
3 clusters for corpus and antrum samples, respectively
(Figure 3).
One of the major corpus gene groups (C4; containing
640 genes) contained the genes whose expression was
characterized by loss of expression in the atrophy
patients (Figure 3). Analysis of enriched functions in C4
revealed that in similarity to the g1-g4 groups from the
integrated analysis (Figure 2), the C4 cluster contains
an over-representation of genes related to parietal cells
including acid secretion and energy metabolism, as well
as genes related to blood vessels and platelet activation
(Figure 3 – “bubbles”; for details see Additional file 1:
Figure S3). These results confirm that the similarities
between antrum and corpus samples of atrophy patients
(Figure 2) is due to diminished expression of corpus-
specific genes in the atrophic corpus, and not to up-
regulation of corpus-related genes in the antrum samples
of atrophy patients. To address this issue further, the
gene clusters were analyzed for enrichment compared
to publicly available datasets. This showed that C4 genes,
which are down-regulated in the corpus mucosa of
atrophy subjects, are indeed strongly associated with
expression in healthy corpus mucosa (p = 7.4 × 10-6;
Table 3), while A1 genes, which are up-regulated in
the antrum tissue of atrophy subjects, are not significantly
associated with expression in normal corpus mucosa
(p =1; Table 3). Taken together, this shows that the
majority of corpus-specific genes and gene groups are
down-regulated in the atrophic corpus tissue, which
leads to a molecular antralization of the corpus mucosa in
corpus-atrophy subjects.
Detailed molecular evidence for simultaneous IM and SPEM
in atrophic corpus tissue, as well as for SPEM development
in non-atrophic H. pylori infected corpus tissue
In addition to a decrease of a substantial number of
corpus-specific genes in atrophic mucosa, there was an
almost equally large set of genes that were markedly
up-regulated in the corpus tissue of atrophy patients.
These genes grouped into the C2.1 cluster, which contains
442 genes (Figure 3). In addition, there were 217 genes
that were up-regulated in both atrophic corpus mucosa
and Hp + non-atrophic corpus mucosa (C2.2 cluster). A
further analysis of C2.1 revealed that a proportion of C2.1
genes were antrum-specific. Using the non-conservative
cut-off of p < 0.05 used in the initial differential analysis
(Figure 1), 18% of the C2.1 genes were significantly
over-expressed in antrum compared to corpus samples
of Hp- subjects. Thus, 80 of the genes up-regulated in
corpus atrophy mucosa were antrum-specific. An example
of such a gene was gastrin (GAST), which showed a
strongly increased expression in corpus mucosa of the
Atr group compared to the Hp- group and Hp + group
(253 fold difference; p = 2.68 × 10-4 and 221 fold-
difference; p = 2.68 × 10-4 respectively).
The functional analysis of C2.1 genes revealed that
the majority of ontologies in this cluster were related
to functions of the intestinal epithelium, including lipid,
cholesterol and sugar transport and metabolism (Figure 3).
Indeed, enrichment analysis of a publicly available dataset,
GSE7307, demonstrated that there was a robust enrich-
ment of small intestinal-specific genes in the C2.1 cluster
(p = 2 × 10-26; Table 3). This strongly indicated that the
C2.1 cluster was related to IM development in the
atrophic mucosa, which agreed with the fact that the
three atrophy patients analyzed by the microarray
exhibited at least mild IM of the corpus according to
Table 3 Gene cluster enrichment (p-values) of tissue-specific genes, as well as of IM and/or SPEM related genes
Gene list Gene cluster
C1 C2.1 C2.2 C3 C4 A1 A2 A3
Cardiac/Fundica 0.92c 0.92 0.92 1 7.42 x10-06 1 1 0.92
Pylorica 1 0.68 1 1 0.10 1 1 0.68
Small Intestinala 1 1.81 x10-26 2.57 x10-02 1 0.82 0.82 1 0.23
Colonica 1 8.78 x10-12 7.67 x10-03 1 1 0.72 1 0.35
IM upb 1 1.96 x10-111 1.21 x10-07 1 1 0.97 1 1
IM/SPEM upb 1 5.25 x10-04 6.16 x10-07 1 1 1 1 1
IM downb 1 1 1 1 5.86 x10-37 1 0.99 1
aP-values less than 0.05 are displayed in bold text. The gene lists were obtained from a publicly available reference dataset “Human Body Index – Transcriptional Profiling”.
bThe gene lists were obtained from [16].
cp-value.
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histopathology assessment (Table 1). To further investigate
the relation to IM, we performed an additional enrichment
analysis compared to a recently published dataset of IM
as well as SPEM marker genes, obtained by microarray
analysis of microdissected human SPEM and IM tissue
[16]. Using this data, we observed that the C2.1 cluster
exhibited an extraordinary enrichment of IM up-regulated
genes (p = 2 × 10-111, Table 3). Importantly, there was also
a significant enrichment of genes observed to increase in
both IM and SPEM tissue (p = 5 × 10-4), indicating that
the antralization of the corpus was associated with SPEM.
Enrichment analysis of the C2.2 cluster, which contained
genes increased in the corpus mucosa of both Hp + and
Atr groups, revealed an equally high association to
genes up-regulated in both SPEM and IM (p = 6 × 10-7),
as with genes increased in IM alone (1 × 10-7, Table 3),
demonstrating a stronger association to SPEM genes
compared to the C2.1 cluster. Furthermore, 43% of the
genes in C2.2 were antrum-specific, as determined by a
p-value cut-off of 0.05 for increased expression in
antrum tissue of Hp- patients. The 5 genes of the C2.2
cluster with the highest antrum-specificity in uninfected
mucosa were MUC17, CEACAM6, CLDN7, SLC6A14
and XDH (55-fold, 27-fold, 24-fold, 15-fold and 11-fold
over-expression in normal antrum vs corpus, respectively).
Some of the gene groups most highly associated with the
C2.2 cluster are related to cell cycle regulation (Figure 3
“bubbles”), which shows that even in the pre-atrophic Hp +
corpus, there are alterations in proliferative regulation,
which may be involved in SPEM development. Strikingly,
there was a strong association with DNA repair genes
within the C1 cluster, i.e. genes up-regulated in Hp +
corpus and then again decreased in the atrophic corpus
mucosa. Thus, while proliferative regulation was altered
in both non-atrophic and atrophic corpus mucosa,
DNA repair genes were increased only in the non-
atrophic tissue.
Analysis of corpus-specific genes lost in the atrophic
mucosa reveals acidic mammalian chitinase as a signature
for atrophy
In order to search for molecular markers for corpus
atrophy, we further investigated which genes were most
strongly down-regulated in the corpus mucosa of atrophy
patients, by performing a regression analysis of corpus
gene expression in the three patient groups (Table 4). This
analysis identified the genes which exhibited progressive
down-regulation from Hp- individuals to the Hp + and
then Atr groups. The gene showing the strongest down-
regulation of corpus gene expression in Atr patients
was acidic mammalian chitinase (AMCase), which is
an enzyme that degrades chitin under acidic conditions.
This gene was also the second most strongly over-
expressed gene in the normal corpus mucosa compared
to in normal antrum (90-fold difference in the microarray,
Table 4). The validity of the regression is shown by the fact
that ATP4B also was among the top genes (Table 4). Other
genes of high interest were chordin (CHRD) which is
known to be involved in cellular differentiation and deve-
lopment, as well as fibrinogen as mentioned above.
We performed RT-PCR analysis of AMCase expression
in order to confirm results obtained by the microarray
analysis. RT-PCR confirmation was also performed for
the ATP4B gene, as well as for PGA5, which are both
known to be down-regulated in atrophic corpus tissue.
RT-PCR analysis indeed confirmed that AMCase expres-
sion was down-regulated, as was expression of ATP4B and
PGA5 (Figure 4). To further verify the loss of AMCase,
we performed Western blot analysis of tissue lysates from
antrum and corpus tissue from a number of patients of
the three groups. This showed that there was an almost
complete loss of AMCase in the atrophic corpus mucosa,
confirming that loss of AMCase expression is a signature
for atrophy. On the individual patient level, there was a
very strong correlation (r2 = 0.92; p < 0.0001) between
mRNA and protein levels, supporting the specificity of the
western blot assay used (Additional file 1: Figure S5).
Discussion
Previously, only a limited number of studies have been
performed to assess the influence of H. pylori infection
on the global gene expression pattern in the human
stomach [20-22]. However, to the best of our knowledge,
this is the first study that uses systems biology tools to
analyze the gene expression profile of human atrophic
gastritis associated with H. pylori infection.
The enrichment analysis of global gene expression
differences between antrum and corpus mucosa of Hp-
patients confirmed to a large extent previous knowledge
on physiological differences. Several of the gene ontologies
associated to over-expression in corpus compared to
antrum mucosa are directly related to the key function
of the corpus, acid secretion (Figure 2, g1). Furthermore, a
large number of corpus-associated ontologies are linked to
energy turnover and mitochondrial function (Figure 2, g2).
This is due to large energy requirements for the fueling of
acid secretion, and is consistent with previous results
showing a higher respiratory capacity of corpus compared
to antrum mucosa [23]. In fact, it has been estimated
that as much as 30–40% of the parietal cell cytoplasmic
volume is occupied by mitochondria [24,25]. The corpus-
associated ontologies related to blood vessel activity is
most likely also linked to the metabolic demands [26] and
animal studies have shown that ischemia of the corpus
tissue leads to rapid necrosis due to the high metabolic
rate and relative lack of ability to use glycolysis [27,28].
The down-regulation of FGA, FGB and other genes
involved in blood clotting and platelet activation in the
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corpus mucosa of the Atr group suggest a dysregulation
of fibrinogen expression in these patients, which could
impair the protection against influx of harmful substances
such as carcinogens into damaged corpus mucosa [29,30].
This may influence the risk of developing severe gastric
diseases such as peptic ulcer or GC and future investiga-
tions of this are warranted.
The transcriptome analysis revealed a 90% depletion
of differences in gene expression between antrum and
corpus tissue in patients suffering from atrophic corpus
gastritis. This was due to antralization of the corpus
mucosa at a global gene expression level – the gene
expression pattern in corpus tissue of atrophy patients
was largely similar to the pattern of antrum mucosa.
Antralization of the corpus is a well-known phenomenon
associated to atrophic gastritis [31]. However, this pheno-
menon has previously mainly been described morpho-
logically and not at the transcriptome level as done in the
present study. It is striking to note that antralization of the
corpus involves differential expression of more than 2000
genes (Figure 1B).
In addition to the loss of corpus-specific genes leading
to antralization of the corpus mucosa, there is also a large
set of genes that are up-regulated in corpus biopsies of
atrophy patients, which is illustrated by the C2.1 cluster
(Figure 3). The majority of the 442 C2.1 genes (> 80%)
are genes not normally over-expressed in antrum mucosa
but contained genes expressed in the small intestinal
Table 4 The genes showing the highest down-regulation of corpus expression in patients with corpus atrophy (ranked
by regression coefficients)
ID Symbol Description Corpus Antrum Fold changeb Clusterc
Ba R2 Ba R2 Hp- Hp+ Atr
ILMN_25453 AMCase chitinase, acidic, transcript variant 1 −3.66 0.69 −0.74 0.04 93 97 2 C4
ILMN_12978 MRGPRD MAS-related GPR, member D −3.32 0.71 −0.59 −0.04 103 100 2 C4
ILMN_27134 CHRD chordin, transcript variant 2 −3.25 0.69 −0.87 0.13 69 65 3 C4
ILMN_24872 AMCase chitinase, acidic, transcript variant 2 −3.24 0.69 −0.65 0.11 37 31 1 C4
ILMN_16471 ATP4A ATPase, H+/K + exchanging, alpha polypeptide −3.03 0.87 −0.78 0.10 46 37 2 C4
ILMN_21851 AQP4 aquaporin 4, transcript variant b −2.80 0.85 −0.74 0.14 27 25 2 C4
ILMN_23805 AGXT2L1 alanine-glyoxylate aminotransferase 2-like 1 −2.77 0.93 −0.48 0.10 27 9 1 C4
ILMN_11251 PTGER3 prostaglandin E receptor 3, transcript variant 9 −2.67 0.85 −0.58 0.07 27 15 2 C4
ILMN_12353 ATP4B ATPase, H+/K + exchanging, beta polypeptide −2.60 0.70 −1.28 0.13 49 46 8 C4
ILMN_11182 FGA fibrinogen alpha chain , transcript variant alpha −2.40 0.90 −0.54 0.10 20 12 2 C4
ILMN_13882 FGB fibrinogen beta chain −2.39 0.89 −0.26 −0.03 31 3 2 C4
ILMN_17569 OGG1 8-oxoguanine DNA glycosylase, transcript variant 1b −2.34 0.66 −0.30 −0.02 17 17 1 C4
ILMN_10755 CKB creatine kinase, brain −2.29 0.88 −0.76 0.39 14 9 2 C4
ILMN_13759 GPR30 G protein-coupled receptor 30, transcript variant 1 −2.28 0.73 −0.51 0.08 19 12 2 C4
ILMN_20448 CPA2 carboxypeptidase A2 (pancreatic) −2.21 0.65 −0.38 −0.09 47 26 4 nc
ILMN_20479 SIGLEC11 sialic acid binding Ig-like lectin 11 −2.20 0.91 −0.38 0.04 13 8 1 C4
ILMN_23656 SH3GL2 SH3-domain GRB2-like 2 −2.18 0.78 −0.26 −0.07 17 12 1 C4
ILMN_28182 FLJ35258 hypothetical protein 284297 −2.18 0.76 −0.38 0.47 16 7 1 C4
ILMN_28694 CDH2 cadherin 2, type 1, N-cadherin (neuronal) −2.17 0.86 −0.20 −0.06 16 7 1 C4
ILMN_5239 FNDC5 fibronectin type III domain containing 5 −2.13 0.88 −0.37 0.29 12 4 1 C4
ILMN_19137 MFSD4 major facilitator superfamily domain containing 4 −2.09 0.86 −0.49 0.16 13 9 1 C4
ILMN_6662 TRIM50 tripartite motif-containing 50 −2.05 0.84 −0.24 −0.07 16 13 1 C4
ILMN_16766 ZNF533 zinc finger protein 533 −2.04 0.85 −0.37 0.07 12 7 1 C4
ILMN_27352 CLIC6 chloride intracellular channel 6 −2.02 0.64 −0.40 −0.05 20 11 2 nc
ILMN_4712 SERPINA5 serpin peptidase inhibitor, clade A, member 5 −2.02 0.88 −0.40 −0.09 14 1 2 C4
ILMN_15602 CLCNKA chloride channel Ka −2.01 0.88 −0.28 −0.06 14 8 1 C4
ILMN_19114 DNER delta-notch-like EGF repeat-containing transmembrane −2.01 0.86 −0.54 0.22 12 5 2 C4
The goodness of fits were also reported by R2;
aRegression coefficient. Linear regression was performed along the three patient groups (Hp-, Hp + and Atr).
bCorpus vs. antrum gene expression fold changes of the individual patient groups.
cThe result from clustering analysis; nc = not included in clustering analysis.
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tissue. This is shown by gene ontology analysis, which
revealed a strong enrichment of intestinal-related gene
functions among C2.1 genes (Figure 3). It also agrees
with previous observations of similar metabolism in IM
as in jejunal mucosa [32]. Furthermore, the intestinal
identity of the C2.1 cluster is clearly shown by its very
strong association (p = 2 × 10-26) to intestinal specific
genes extracted from a public dataset (Table 3). In
addition, the C2.1 genes were close to identical (p = 2 ×
10-111) to a list of IM-related genes, obtained using
laser-capture microdissection of IM mucosa [16]. The
gastrin gene (GAST) was also among the C2.1 cluster
genes with the most highly up-regulated expression
in atrophic corpus mucosa. This is clearly not a gene
related to IM development, but was the one gene
with the highest over-expression in healthy antrum
vs. corpus tissue on the array (847-fold difference).
Interestingly, the expression of GAST increased 240-fold
in corpus mucosa of Atr group compared to the rest of
the groups. This strongly indicates de-novo expression
of GAST in corpus tissue and agrees well with a previous
report showing that gastrin production is highly associated
with antralization of the incisura angularis in Hp + indi-
viduals [33].
Several studies have revealed that the process of
antralization is characterized by a novel metaplastic
transformation of cells in the corpus glands. This dis-
tinct novel cell type has been termed SPEM [34]. The
presence of SPEM in the corpus atrophy samples is
confirmed by strong association of C2.2 to IM and/or
SPEM-related genes relative to IM only genes (p = 6 × 10-7
and 1 × 10-4, respectively; Table 3). Interestingly, the
genes of the C2.2 cluster are up-regulated in corpus tissue
of both Hp + and Atrophy groups, suggesting that
SPEM-associated genes are up-regulated in the corpus
mucosa in Hp + patients even in the absence of corpus-
predominant atrophy. It could be argued that these
findings may be due to misclassification of the patients,
due to patchy distribution of atrophy and the fact that
histology assessment and microarray analysis were per-
formed on separate biopsies. However, analysis of the data
from the microarray concerning individual genes known
to be down-regulated in the atrophic corpus tissue clearly
demonstrates prominent corpus atrophy in the Atr group
but not in the Hp + group. For example, the expression
of ATP4B was 46-fold and 36-fold higher in corpus
than antrum tissue in Hp- and Hp + groups, while only
2-fold higher in the Atr group.
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Figure 4 Gene and protein expression in antrum and corpus mucosa. A, B and C: RT-qPCR verification of H+/K+ ATPase, ATP4B (A),
pepsinogen, PGA5 (B) and acidic chitinase, AMCase (C) versus the reference gene HPRT is shown. D and E: AMCase protein levels analysed with
Western Blot. Band intensities were normalized against isotype control antibody (D). A representative blotting image is shown (E); the full image
is shown in Additional file 1: Figure S4. The deduced molecular mass of the full length AMCase is 49.9 kDa. Each dot represent one patient
sample. The median level is indicated with a horizontal bar, and the interquartile range indicated. Results from both antrum and corpus mucosa
from the three patient groups (Hp-, Hp+, Atr) are shown (A = antrum; C = corpus).
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It is striking to note that out of the 217 genes of the
C2.2 cluster, 43% were antrum-specific in Hp- patients.
Thus, the global transcriptome change reflected in cluster
C2.2 is also strongly associated with antralization, and
is likely not confined to changes associated only with
the SPEM cell lineage.
The clustering analysis revealed the interesting fact
that while proliferation and DNA repair genes both are
up-regulated in the Hp + corpus mucosa (Figure 3; clusters
C1 and C2.2), proliferation genes but not DNA repair
genes are up-regulated in atrophic corpus gastritis. We
hypothesize that this gene expression pattern leads to
an increased occurrence of mutations in the atrophic
corpus mucosa and may therefore be an important
factor leading to the increased GC risk associated
with atrophic gastritis. Interestingly, the novel atrophy
model induced by activation of cre recombinase, shows
that corpus epithelial cells are especially susceptible to
DNA damage [35].
To find genes that may be used as novel molecular
markers for corpus atrophy, we analyzed the most strongly
down-regulated genes in the corpus mucosa of the Atr
group. One striking finding from the analysis of genes
down-regulated in corpus atrophy is CHRD. This gene
exhibited a 30-fold relative reduction in expression in
the atrophic corpus mucosa compared to Hp- and Hp +
individuals (Table 4). Interestingly, CHRD is a potent
negative regulator of bone morphogenic protein (BMP)
signaling [36], which is of great importance for the
development and differentiation of gastric epithelial cells
[37]. Furthermore, mouse studies have shown that loss
of BMP signaling can lead to GC development [38].
Taken together, this shows that the role of CHRD in
the development of atrophy and GC in humans deserves
further study.
The top gene in this list (Table 4) was acidic mammalian
chitinase, AMCase. We confirmed the mRNA and protein
expression of AMCase in normal corpus mucosa, and
its strong down-regulation in atrophic corpus tissue
(Figure 4). AMCase is a chitin-degrading enzyme which
is active under acidic conditions, and has been shown
to be expressed in chief cells of mammals [39,40]. In
contrast to our results, two recent studies described
very low or absent levels of AMCase mRNA and/or
protein in human stomach [41,42]. However, the mRNA
tested in at least one of those studies was from antrum
tissue [42], and we indeed show that AMCase is
expressed only in the corpus (Figure 4). Furthermore,
different antibodies were used for the protein assays in
our study and the conflicting study, which may explain
the different protein results obtained. The specificity of
our western blot assay is supported by a very strong
correlation between mRNA and protein levels (r2 = 0.92;
Additional file 1: Figure S5).
AMCase has been extensively studied in pulmonary
tissue where it protects epithelial cells from FasL- and
growth factor withdrawal-induced apoptosis. This auto-
crine or paracrine pro-survival effect is associated with
the PI3K/Akt pathway and is independent of its chitinase
activity [43]. It has also been shown to play an immune-
modulatory role both through its chitinolytic effects
but also by stimulating Th2-cells in the pathogenesis of
asthma [44]. The loss of chitinase in corpus atrophy
might lead to an increased sensitivity to apoptosis and a
more Th1-oriented response to H. pylori infection, leading
to increased tissue damage and severity of disease.
Conclusions
In conclusion, global transcriptome analysis clearly showed
that antralization of the corpus mucosa in atrophic gastritis
due to H. pylori infection is associated with lost expression
of corpus-related gene groups, such as genes related to acid
secretion, energy metabolism and blood clotting. In parallel
with antralization, corpus atrophy is also associated with
increased expression of genes related to inflammation and
cell signaling. Furthermore, we propose that loss of expres-
sion of acidic mammalian chitinase in the corpus tissue
may be used as a novel molecular signature for atrophic
gastritis.
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